Home>>5-[(3-Indolyl)propionamide-N-allyl]-2'-deoxyuridine-5'-Triphosphate

5-[(3-Indolyl)propionamide-N-allyl]-2'-deoxyuridine-5'-Triphosphate

Catalog No.GN20101

Products are for research use only. Not for human use. We do not sell to patients.

5-[(3-Indolyl)propionamide-N-allyl]-2'-deoxyuridine-5'-Triphosphate Chemical Structure

Size Price Stock Qty
250nmole
$363.00
In stock
1µmole
$1,280.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product Documents

Quality Control & SDS

View current batch:

Description

5-Indolyl-AA-dUTP is another nucleotide analog which can be incorporated during PCR. 5-Indolyl-AA-dUTP (Tryptamino-dUTP) allows for introduction of functionality analogous to the amino acid, Tryptophan into the sequence of interest. When incorporated during selection schemes, the chemical diversity of aptamers can be expanded to include the properties of proteins.

Product Details

purity >90.00% Extinction Coefficient 9,057 Lmol-1cm-1 at 283 nm
Formula C23H29N4O15P3 (free acid) M.Wt 694.40 g/mole (free acid)
Salt Form Li+ Concentration 100 mM
Buffer H2O Storage -20°C or below
Synonyms 5-Indolyl-AA-dUTP,Tryptamino-dUTP Analog Backbone 5'-Triphosphate
Base Analog Thymidine, Uridine Sugar Type DNA
Nucleotide Category Base Modified DNA
Applications Aptamers, Epigenetics/DNA Damage, In vitro Transcription, Mutagenesis, Photocrosslinking Studies

Reviews

Review for 5-[(3-Indolyl)propionamide-N-allyl]-2'-deoxyuridine-5'-Triphosphate

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 5-[(3-Indolyl)propionamide-N-allyl]-2'-deoxyuridine-5'-Triphosphate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.